NHS Trust Customer Wins

RNS Number : 8730R

Osirium Technologies PLC

11 March 2021

 

11 March 2021

Osirium Technologies plc

("Osirium" or "the Group")

NHS Trust Customer Wins

Osirium Technologies plc (AIM: OSI.L), a leading vendor of cybersecurity software, is pleased to announce it has strengthened its position in the public sector through a series of NHS trust customer wins for its Privileged Access Management (PAM) solution.

These new customer wins follow on from a cybersecurity guidance by the National Cyber Security Centre and a NHS Digital initiative, launched towards the end of 2020, which provided funding to NHS trusts for privileged access solutions to address the mounting challenge from ransomware targeting backup systems.  

The Group responded rapidly to this initiative and is pleased to report nine new NHS trust customers since the beginning of February, with these deals providing significant upsell opportunities in line with Osirium's "land and expand" strategy.  

Notably, these customer wins were secured in collaboration with three of the Group's channel partners, demonstrating the growing contribution of the indirect channel to Osirium's sales. The Group is experiencing increasing traction across a wide range of markets through these domestic and international partners, working more closely with them through joint marketing campaigns.

With these recently signed contracts, Osirium now counts a growing number of NHS trusts as customers. The Group continues to see a healthy pipeline of further deals in this field and, as part of its ambition to become a key player in UK healthcare, will continue to target the remaining NHS trusts in collaboration with its partners.  

David Guyatt, Chief Executive Officer, said:

"We're delighted to have secured these new NHS trust customers. These new contracts reflect not only the growing attention now paid to privileged access security across public healthcare but the importance of Osirium's indirect channels to our sales.

With bookings momentum continuing from our record Q4 last year, we look forward to securing more deals of this nature as well as exploring the significant upsell opportunities presented by these initial contracts through our proven "land and expand" strategy."

-  Ends -

For further information:

Osirium Technologies plc	Tel: [phone]
David Guyatt, Chief Executive Officer Rupert Hutton, Chief Financial Officer www.osirium.com
Stifel Nicolaus Europe Limited (Nominated Adviser and Broker)	Tel: [phone]
Fred Walsh / Richard Short
Alma (Financial PR) David Ison / Josh Royston / Kieran Breheny	Tel: [phone]

Notes to Editors:

Osirium Technologies plc (AIM: OSI) operates in one of the fastest growing parts of the cybersecurity market and is a leading vendor of Privileged Access Security solutions. Osirium's cloud-based products protect critical IT assets, infrastructure and devices by preventing targeted cyber-attacks from directly accessing Privileged Accounts, removing unnecessary access and powers of Privileged Account users, deterring legitimate Privileged Account users from abusing their roles and containing the effects of a breach if one does happen.

Osirium has defined and delivered what the Directors view as the next generation Privileged Access Management solution. Osirium's award-winning Privileged Task Management module further strengthens Privileged Account Security by minimising the cyber-attack surface and delivering an impressive return on investment benefits for customers. Building on Osirium's Privileged Task Management module, in May 2019 Osirium launched Privileged Process Automation, providing a highly-flexible platform for automating essential IT processes to set a new benchmark in IT Process Automation. This was followed by the launch of Privileged Endpoint Manager in December 2019, bringing the total portfolio to three complementary solutions.

Founded in 2008 and with its headquarters in Reading, UK, the Group was admitted to AIM in April 2016. For further information please visit www.osirium.com.

 

END

 

 

NRAFFFEIVEIILIL